Unknown

Dataset Information

0

Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond

ABSTRACT:

SUBMITTER: Guilpain P 

PROVIDER: S-EPMC8514991 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Key fibrogenic mediators: old players. Renin-angiotensin system.
| S-EPMC4536968 | biostudies-other
Unknown Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast.
| S-EPMC6364098 | biostudies-literature
Unknown Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.
| S-EPMC6703857 | biostudies-literature
Unknown Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.
| S-EPMC8257022 | biostudies-literature
Unknown Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence.
| S-EPMC4981669 | biostudies-other
Unknown JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.
| S-EPMC6390879 | biostudies-literature
Unknown Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response.
| S-EPMC6593412 | biostudies-literature
Unknown Tie2 as a novel key factor of microangiopathy in systemic sclerosis.
| S-EPMC5445339 | biostudies-literature
Unknown RANKL biology: bone metabolism, the immune system, and beyond.
| S-EPMC7006158 | biostudies-literature
Unknown Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.
| S-EPMC8116828 | biostudies-literature